QQQ $ 459.86 $ 0.43 (0.09 %)
DIA $ 407.95 $ -1.96 (-0.48 %)
SPY $ 548.56 $ -1.34 (-0.24 %)
TLT $ 99.56 $ 0.56 (0.57 %)
GLD $ 232.35 $ 1.92 (0.83 %)
$ 0.03
-- x --
-- x --
-- - --
$ 0.03 - $ 0.03
9,000
na
2.9M
nm
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2024 06-30-2024 10-Q
2 04-25-2024 03-31-2024 10-Q
3 02-01-2024 12-31-2023 10-K
4 10-18-2023 09-30-2023 10-Q
5 07-21-2023 06-30-2023 10-Q
6 04-24-2023 03-31-2023 10-Q
7 02-24-2023 12-31-2022 10-K
8 10-28-2022 09-30-2022 10-Q
9 08-02-2022 06-30-2022 10-Q
10 05-02-2022 03-31-2022 10-Q
11 03-14-2022 12-31-2021 10-K
12 11-02-2021 09-30-2021 10-Q
13 08-04-2021 06-30-2021 10-Q
14 05-11-2021 03-31-2021 10-Q
15 03-18-2021 12-31-2020 10-K
16 11-02-2020 09-30-2020 10-Q
17 08-05-2020 06-30-2020 10-Q
18 05-06-2020 03-31-2020 10-Q
19 02-18-2020 12-31-2019 10-K
20 11-06-2019 09-30-2019 10-Q
21 08-01-2019 06-30-2019 10-Q
22 05-08-2019 03-31-2019 10-Q
23 02-27-2019 12-31-2018 10-K
24 11-14-2018 09-30-2018 10-Q
25 08-09-2018 06-30-2018 10-Q
26 05-08-2018 03-31-2018 10-Q
27 03-22-2018 12-31-2017 10-K
28 11-09-2017 09-30-2017 10-Q
29 08-03-2017 06-30-2017 10-Q
30 05-15-2017 03-31-2017 10-Q
31 03-21-2017 12-31-2016 10-K
32 11-14-2016 09-30-2016 10-Q
33 08-09-2016 06-30-2016 10-Q
34 05-11-2016 03-31-2016 10-Q
35 03-17-2016 12-31-2015 10-K
36 11-12-2015 09-30-2015 10-Q
37 08-11-2015 06-30-2015 10-Q
38 05-12-2015 03-31-2015 10-Q
39 03-19-2015 12-31-2014 10-K
40 11-12-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Oruka Therapeutics, Inc. ("Oruka") (NASDAQ:ORKA), a biotechnology company developing novel biologics designed to set a ...

 reported-earlier-arca-biopharma-updates-special-dividend-to-1613share-in-preparation-for-oruka-therapeutics-merger

ARCA biopharma updates the previously announced final amount of the special cash dividend (the "Special Dividend"), whi...

 arca-biopharma-announces-1-for-12-reverse-stock-split-in-connection-with-the-proposed-merger-with-oruka-therapeutics-to-begin-trading-on-a-post-reverse-stock-split-basis-on-the-nasdaq-global-market-on-september-3-2024-and-under-the-new-symbol-orka

ARCA biopharma, Inc. (NASDAQ:ABIO) ("ARCA") today announced that its Board of Directors (the "Board") has appro...

 why-arca-biopharma-shares-are-trading-higher-today

ARCA Biopharma shares are trading higher by 8.1% Monday morning. The company announced a special dividend of $1.59 per share.

 arca-biopharma-declares-special-dividend-of-159

Special dividend estimated to be $1.59 per share Payment of special dividend conditioned upon ARCA stockholder approval of the ...

 gamestop-trader-roaring-kitty-sparks-wall-street-rally-in-heavily-shorted-stocks-what-you-need-to-know-right-now

The madness in meme stocks on Monday can be traced back to a social media post from Keith Gill, best known as "Roaring Kitt...

 arca-biopharma-q1-eps-014-down-from-009-yoy

ARCA biopharma (NASDAQ:ABIO) reported quarterly losses of $(0.14) per share. This is a 55.56 percent decrease over losses of $(...

 arca-biopharma-13d-filing-shows-adage-capital-management-lp-reported-a-828-stake-in-the-co-as-of-april-3-2024

- SEC Filing

 why-staar-surgical-shares-are-trading-higher-by-around-13-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong prelimi...

 why-flora-growth-shares-are-trading-lower-by-around-20-here-are-20-stocks-moving-premarket

Shares of Flora Growth Corp. (NASDAQ: FLGC) fell sharply in today’s pre-market trading after the company reported the launch ...

 nasdaq-gains-75-points-acuity-brands-posts-upbeat-earnings

U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining around 0.3% on Wednesday. The Dow traded up ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION